News

Adherium Enteres Rapid US Commercialisation Phase

Posted: 1 August 2023 Adherium Limited (ASX: ADR), a leading provider of respiratory eHealth, remote monitoring and data management solutions, today announced it is entering a rapid commercialisation phase in reimbursed remote patient monitoring in the globally significant…

Advertising of Health Services – New Advertising Guidelines – Is your advertising compliant?

Posted: 31 July 2023 “This article provides an update on the new Medical Board/AHPRA “Guidelines For Registered Medical Practitioners who Advertise Cosmetic Surgery” which came into effect on 1 July 2023. Health practitioners, individuals, businesses, and companies involved…

Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned

Posted: 27 July 2023 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that an independent Data Monitoring Committee (DMC) recommended the ATH434-201…

Certification paves the way for improved translational research

Posted: 27 July 2023 The Burnet Diagnostics Initiative (BDI) has reached a major milestone, having recently been awarded ISO 9001 certification. It is a significant step forward for the BDI, which has a strong focus on translational research, including developing…

Expanded Cell and Gene Therapy Manufacturing Facility Opens at Peter Mac

Posted: 27 July 2023 Australia’s only biomedical manufacturing site where CAR T-cells and other “living” cancer therapies can be made at commercial scale has expanded to meet future patient demand. Federal Minister for Health and Aged Care, the…

New Commercial-Scale Cell and Gene Therapy Manufacturing Facility for APAC Market Supply

Posted: 27 July 2023 Cell Therapies Pty Ltd. is excited to announce the opening of new cell and gene therapy GMP manufacturing facilities to meet future patient demand at the Peter MacCallum Cancer Centre. As Australia’s only biomedical…

BioCurate Announces Strategic Alliance with the Experimental Drug Development Centre in Singapore

Posted: 27 July 2023 Partnership will see co-investment and collaboration to advance promising biomedical research. BioCurate, an independently operated joint venture between the University of Melbourne and Monash University, announced today it has signed a Memorandum of Understanding…

Research to merge human brain cells with AI secures prestigious grant funding

Posted: 27 July 2023 Monash University-led research into growing human brain cells onto silicon chips, with new continual learning capabilities to transform machine learning, has been awarded almost $600,000 AUD in the prestigious National Intelligence and Security Discovery…

New research shows AI can ask another AI for a second opinion on medical scans

Posted: 27 July 2023 Researchers at Monash University have designed a new co-training AI algorithm for medical imaging that can effectively mimic the process of seeking a second opinion. Published recently in Nature Machine Intelligence, the research addressed the…

Starpharma partners with UQ to advance DEP radio pipeline

Posted: 26 July 2023 Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it has entered a new partnership with The University of Queensland’s (UQ’s) Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub), which has been awarded $4.8 million from…

Immuron enrols first patients in Travelan clinical study

Posted: 26 July 2023 Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has enrolled its first cohort of 30 participants into the Travelan® clinical trial to evaluate its efficacy to prevent infectious diarrhea caused by enterotoxigenic Escherichia coli (ETEC). Travelan® is known to…

Specialist Digital Health Workforce Census 2023

Posted: 26 July 2023 Are you part of the specialist digital health workforce? Are you responsible for health data, information, knowledge, or technology? Be part of the census that captures the vital information about this workforce. This information…

Home

News & opinion

Member Directory

Events